| RS2503048132 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503048142 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503048651 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503049019 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503049635 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503054402 |
DDHD1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 28, Hereditary spastic paraplegia 28 |
| RS2503055611 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503056792 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503056894 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503057230 |
F7
|
Health Risk |
Likely pathogenic |
Congenital factor VII deficiency, Congenital factor VII deficiency |
| RS2503057247 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503058049 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503060145 |
SPTB
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503060154 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503060181 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503060526 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503060553 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503060655 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503060786 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503060918 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503061238 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503061513 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503063102 |
PSEN1
|
Health Risk |
Likely pathogenic |
Alzheimer disease 3, Acne inversa |
| RS2503063306 |
PSEN1
|
Health Risk |
Pathogenic |
Alzheimer disease 3, Frontotemporal dementia |
| RS2503065505 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503065637 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503065866 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503066387 |
SPTB
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 2, SPTB-related disorder |
| RS2503070132 |
SPTB
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503070664 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503070978 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503071579 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503071678 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503071813 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503074347 |
IRF2BPL
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS2503074426 |
IRF2BPL
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2503074542 |
IRF2BPL
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS2503074890 |
IRF2BPL
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2503075312 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
— |
| RS2503075725 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2503075934 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS2503075991 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS2503076331 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
IRF2BPL-related disorder, IRF2BPL-related disorder |
| RS2503076418 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS2503076637 |
IRF2BPL
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2503076688 |
COQ6
|
Health Risk |
Pathogenic |
— |
| RS2503078022 |
IRF2BPL
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS2503078108 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS2503078190 |
IRF2BPL
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS2503078573 |
IRF2BPL
|
Health Risk |
Pathogenic |
— |
| RS2503078768 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2503078942 |
IRF2BPL
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS2503078947 |
IRF2BPL
|
Health Risk |
Pathogenic |
— |
| RS2503079126 |
IRF2BPL
|
Health Risk |
Pathogenic |
— |
| RS2503079188 |
IRF2BPL
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS2503081410 |
F10
|
Health Risk |
Likely pathogenic |
Hereditary factor X deficiency disease, Hereditary factor X deficiency disease |
| RS2503081595 |
F10
|
Health Risk |
Likely pathogenic |
Hereditary factor X deficiency disease, Hereditary factor X deficiency disease |
| RS2503083810 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS2503084712 |
FANCM
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Spermatogenic failure 28 |
| RS2503085082 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503087732 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503087761 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503087933 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2503090474 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503090652 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503091112 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503091165 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503091365 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503091656 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503091962 |
NEMF
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with speech delay and axonal peripheral neuropathy, Intellectual developmental disorder with speech delay and axonal peripheral neuropathy |
| RS2503092135 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503093700 |
DDHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2503094311 |
F10
|
Health Risk |
Likely pathogenic |
Hereditary factor X deficiency disease, Hereditary factor X deficiency disease |
| RS2503094343 |
F10
|
Health Risk |
Likely pathogenic |
Hereditary factor X deficiency disease, Hereditary factor X deficiency disease |
| RS2503095549 |
F10
|
Health Risk |
Likely pathogenic |
Hereditary factor X deficiency disease, Hereditary factor X deficiency disease |
| RS2503095616 |
F10
|
Health Risk |
Likely pathogenic |
Hereditary factor X deficiency disease, Hereditary factor X deficiency disease |
| RS2503095628 |
F10
|
Health Risk |
Likely pathogenic |
Hereditary factor X deficiency disease, Hereditary factor X deficiency disease |
| RS2503102733 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503102750 |
FANCM
|
Health Risk |
Likely pathogenic, low penetrance |
Premature ovarian failure 15, Premature ovarian failure 15 |
| RS2503102921 |
SPTB
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503102939 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503102948 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503103844 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503104309 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503106913 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503109144 |
ZMYM2
|
Health Risk |
Pathogenic |
Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities |
| RS2503110158 |
FANCM
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2503112149 |
ZMYM2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities |
| RS2503112553 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503113076 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503113857 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503119018 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503119189 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503119393 |
SPTB
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS2503119796 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503120102 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2503121282 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2503121304 |
SPTB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2503121647 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2503122151 |
FANCM
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |